What is Lumeda?
Lumeda is a medical technology company focused on revolutionizing the treatment of non-small cell lung cancer (NSCLC) and other thoracic malignancies through advanced photodynamic therapy (PDT). The company leverages cutting-edge photonics and proprietary software to automate and refine PDT light delivery, aiming to enhance treatment efficacy, simplify clinical application, and improve treatment planning. With a multidisciplinary team possessing decades of experience in the photonics industry, including systems engineering and new technology commercialization, Lumeda is dedicated to pioneering advancements in PDT for better patient outcomes.
How much funding has Lumeda raised?
Lumeda has raised a total of $4.3M across 1 funding round:
Series A
$4.3M
Series A (2021): $4.3M with participation from Connecticut Innovations and Cycle Venture Partners
Key Investors in Lumeda
Connecticut Innovations
Connecticut Innovations (ctinnovations.com) is Connecticuts strategic venture capital arm and quasipublic investment agency, providing equity and debt financing, strategic guidance, and connections to help innovative, growing companies in the state scale, with dedicated funds for sectors like AI/quantum, climate tech, and biosciences.
Cycle Venture Partners
Cycle Venture Partners is an investment firm that provides capital for companies. Further details on their specific investment focus are not readily available.
What's next for Lumeda?
The recent major strategic investment signals a significant growth phase for Lumeda, likely enabling the company to scale its operations, further develop its technology, and expand its market reach. This capital infusion is expected to accelerate the commercialization of its automated PDT light delivery system, positioning Lumeda to capture a larger share of the oncology treatment market. Future strategic initiatives may involve clinical trial expansions, regulatory approvals, and partnerships to broaden the application of its innovative PDT solutions.
See full Lumeda company page